Indivior Pharmaceuticals (INDV) Accounts Payables (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Accounts Payables of $178.0 million for Q1 2026, down 2.73% year-over-year from $183.0 million in Q1 2025, and down 28.8% quarter-over-quarter from $250.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Accounts Payables (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Accounts Payables history runs 6 years deep, the most recent figure standing at $178.0 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 2.73% year-over-year to $178.0 million; the TTM figure through Mar 2026 stood at $178.0 million (down 2.73% YoY), while the FY2025 annual figure was $250.0 million, up 15.74% from the prior year.
- Accounts Payables for Q1 2026 stood at $178.0 million, down from $250.0 million in the prior quarter.
- The five-year high for Accounts Payables was $617.0 million in Q4 2022, with the low at $178.0 million in Q1 2026.
- The 5-year median for Accounts Payables is $205.5 million (2025), against an average of $256.2 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables plunged 68.4% in 2023, then gained 15.74% in 2025.
- Indivior Pharmaceuticals' Accounts Payables stood at $617.0 million in 2022, then slumped by 68.4% to $195.0 million in 2023, then increased by 10.77% to $216.0 million in 2024, then rose by 15.74% to $250.0 million in 2025, then dropped by 28.8% to $178.0 million in 2026.
- Business Quant data shows INDV's Accounts Payables at $178.0 million in Q1 2026, $250.0 million in Q4 2025, and $215.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 206.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 206.00 Mn |
| Mar 31, 2026 | 178.00 Mn |
| Dec 31, 2025 | 250.00 Mn |
| Sep 30, 2025 | 215.00 Mn |
| Jun 30, 2025 | 196.00 Mn |
| Mar 31, 2025 | 183.00 Mn |
| Dec 31, 2024 | 216.00 Mn |
| Dec 31, 2023 | 195.00 Mn |
| Dec 31, 2022 | 617.00 Mn |
| Dec 31, 2021 | 720.00 Mn |